FDA, NIH mark milestones toward reducing animal testing
· mari serebrov
AI Briefing
- FDA publishes draft guidance on accelerating human-centric data for animal testing
- Agency aims to reduce animal studies in drug development
- New approach methodologies to bring safe, effective drugs to market sooner
Advertisement